--- title: "融創中國:境內債務重組方案獲相關債權人批准" description: "融創中國宣佈,其境內債務重組方案已獲得相關債權人批准。根據公告,十筆債券的重組方案將調整本息償付安排,提供包括現金要約收購、股票及/或股票經濟收益權兑付等選項。接下來,融創房地產將安排債券持有人選擇和分配重組方案選項。" type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/225694059.md" published_at: "2025-01-21T13:07:03.000Z" --- # 融創中國:境內債務重組方案獲相關債權人批准 > 融創中國宣佈,其境內債務重組方案已獲得相關債權人批准。根據公告,十筆債券的重組方案將調整本息償付安排,提供包括現金要約收購、股票及/或股票經濟收益權兑付等選項。接下來,融創房地產將安排債券持有人選擇和分配重組方案選項。 智通財經 APP 訊,融創中國 (01918) 發佈公告,如融創房地產於 2024 年 12 月至 2025 年 1 月期間於上海證券交易所網站及深圳證券交易所網站刊發的公告所載, 融創房地產十筆債券的重組方案已全部經相關債券持有人會議審議通過,將對十筆債券的本息償付安排進行調整,並提供包括債券購回 (即現金要約收購)、股票及/或股票經濟收益權兑付及以資抵債等重組方案選項。融創房地產下一步將根據債券持有人會議議案相關條款的約定, 安排債券持有人就其持有的債券在重組方案選項中進行選擇及分配。 ### Related Stocks - [01918.HK - 融創中國](https://longbridge.com/zh-HK/quote/01918.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | BCII Receives Very Favorable Accounting Treatment Opinion for Its Coupon Token Program \| BCII Stock News | BCII Enterprises Inc. announced a favorable accounting treatment opinion for its Coupon Token platform from CFO Squad In | [Link](https://longbridge.com/zh-HK/news/276452246.md) | | Ubar Hotels And Resorts Board Considering To Acquire Al Sawadi Beach Resort | UBAR HOTELS AND RESORTS SAOGM):UBAR HOTELS AND RESORTS - BOARD CONSIDERING TO ACQUIRE AL SAWADI BEACH RESORT | [Link](https://longbridge.com/zh-HK/news/276095095.md) | | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/zh-HK/news/276024005.md) | | KUB Coin (KUB) - Validators Vote - 20 Feb–08 Mar 2026 | KUB Chain is conducting a governance vote on the proposal for "Single-Tier Validators for Lowering Barriers & Boosting E | [Link](https://longbridge.com/zh-HK/news/276434774.md) | | Alibaba (BABA) Upgrades Qwen AI Model as China's Tech Giants Battle for Users | Alibaba has upgraded its AI model to Qwen3.5, enhancing its capabilities in text, image, and video processing. This move | [Link](https://longbridge.com/zh-HK/news/276055492.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。